Non-peptide
Fisetin
Also known as
3,3',4',7-tetrahydroxyflavone · 3,3′,4′,7-Tetrahydroxyflavone · Fisetin flavonoid · Natural fisetin · Senolytic fisetin (discussion label) · Novusetin (branded ~95% fisetin extract, often Rhus-derived) · Cognisetin (marketing / memory-branded fisetin label) · FF-20 / hybrid-hydrogel fisetin (enhanced-bioavailability research form)
Community talk. May contain inaccuracies. Not medical advice. Not a protocol. Not for human or animal use.
What it is
| Plant supplement | An oral plant flavonol discussed for aging-cell removal, joint comfort and mental sharpness. Occasional high-amount pulses and smaller daily use pursue different goals. |
|---|---|
| Form matters | Plain powder, extracts, liposomal liquids and complexes are not interchangeable by label milligrams. |
Notes
Fisetin is a plant flavonol sold as an oral supplement. Longevity communities discuss it for aging cells, joint comfort and mental sharpness, usually as an occasional high-amount pulse or a smaller daily habit. Reports include improvement, no noticeable change and unwanted effects; feeling different does not show that aging cells were removed.
A plant compound with two different use stories. Flavonol means a type of plant polyphenol. Senescent cells have stopped dividing and can release inflammatory signals; “senolytic” means an agent intended to remove them. Pulse users pursue that idea, while daily users often seek ordinary symptom comfort. These goals are different. Yousefzadeh et al. — Fisetin is a senotherapeutic that extends health and lifespan (Animal context · Accessed 2026-09-30) · Fisetin protocol (Community discussion · Accessed 2026-09-30)
Oral forms matter. Capsules, powder, Novusetin extracts, liposomal liquids and hydrogel complexes appear in discussions. People argue about meals, oils, fasting and split versus single daily amounts. Equal milligrams on two labels do not establish equal absorption. Mega dose fisetin experience (Personal report · Accessed 2026-09-30)
Source context — Yousefzadeh et al. — Fisetin is a senotherapeutic that extends health and lifespan: Mouse and tissue-explant findings, not clinical human longevity. Acute gavage and chronic dietary experiments must remain separate.
Source context — Fisetin protocol: One brief discussion, not population prevalence or comparative efficacy; the reply's assertion that low doses are useless is unsupported.
Source context — Mega dose fisetin experience: Deleted author identity; short evolving log with co-agent, no complete long-term follow-up. A planned four-night course is not verified completion.
What people notice
| Reported changes | Some describe less stiffness, easier movement, better well-being or sharper thinking. Feeling different does not prove aging-cell removal. |
|---|---|
| Unwanted changes | Accounts also include fatigue, back-pain flares and weeks of brain fog. A knee-osteoarthritis trial abstract reported no significant pain, function or cartilage benefit versus placebo. |
Notes
Less stiffness, easier movement and better well-being. One monthly-pulse reply described better joints after typing, better-looking skin and less-grey hair. Another poster's old back injury flared instead. These observations do not establish cartilage repair or reversal of aging. High dose Fisetin (1500MG) as senolytic (Personal report · Accessed 2026-09-30)
Easier word-finding, nasal comfort and other reported changes. Older accounts mention word-finding, training drive, nasal comfort and reduced nighttime urinary urgency. They also include people noticing nothing for weeks. These remain separate reported experiences, rather than a single expected benefit.
Fisetin is a plant flavonol sold as an oral supplement. Longevity communities discuss it for aging cells, joint comfort and mental sharpness, usually as an occasional high-amount pulse or a smaller daily habit. Reports include improvement, no noticeable change and unwanted effects; feeling different does not show that aging cells were removed.
Human joint results temper the testimonials. A 2025 primary conference abstract reported no significant pain, function or cartilage benefit versus placebo in a 74-person knee-osteoarthritis trial. That result applies to its formulation and three-course schedule, not every community experiment. Tashman et al. — randomized fisetin knee osteoarthritis trial results (Official context · Accessed 2026-09-30)
Unwanted effects can outlast dosing. A LongeCity author recalls 400 mg one day and 500 mg the next, followed by brain fog for weeks. Product identity and causation were not independently checked. massive, long-lasting brainfog after last Fisetin dose (Personal report · Accessed 2026-09-30)
An unwanted effect can arrive first. One multi-ingredient pulse account describes fatigue within eight hours, while allowing possible illness. That is an adverse-symptom onset, not evidence that cell clearance started. Fatigue After Taking Senolytic? (Personal report · Accessed 2026-09-30)
Source context — High dose Fisetin (1500MG) as senolytic: Unverified self-reports; mixed formulations and rapamycin co-use. Repeated couple comment is one account. No dose-response or tissue-repair measurement.
Source context — Tashman et al. — randomized fisetin knee osteoarthritis trial results: Conference abstract, not a full clinical publication. Particular formulation, disease and schedule; cannot determine every fisetin use or long-term safety.
Source context — massive, long-lasting brainfog after last Fisetin dose: Retrospective amounts uncertain; no independent diagnosis or product verification. Replies are distinct experiences, not confirmations of causation.
Source context — Fatigue After Taking Senolytic?: Multiple co-agents, possible virus and different users; no proof of senolysis. No amount specified for #11.
Doses people talk about
| Oral pulses | Older reports cluster around 1,000–1,800 mg per day on pulse days. Opened examples include 1,500 mg on each of 2–3 days and 1,000 mg/day for three days with quercetin. |
|---|---|
| Trial-origin arithmetic | 20 mg/kg/day, often copied for two days, gives 1,400 mg each day for 70 kg. That is a daily total, not the whole course or a recommended regimen. |
| Lower amounts | 100–500 mg/day continuous use and 100 mg twice daily for two days are separate reported patterns; one comment reports 100 mg three times daily. |
| Outliers | Logs also include about 1 g/day for 10–15 days and a 4 g nightly experiment with BioPerine 40 mg whose early no-negative-effects update later changed. |
Notes
Oral pulses: 1,000–1,800 mg total per day in the older record. Opened examples differ: 1,500 mg on each of 2–3 days, approximately 1,700 mg on each monthly pulse day, or 1,000 mg/day for three days with quercetin 1,200 mg/day. These are reports, not a recommended range. High dose Fisetin (1500MG) as senolytic (Personal report · Accessed 2026-09-30) · Fisetin protocol (Community discussion · Accessed 2026-09-30)
20 mg/kg/day is copied from trial language. The community's 1,400 mg/day example for 70 kg, or 1,200–1,600 mg/day for 60–80 kg, is arithmetic from that study template. It is a daily total on each pulse day, not the total for a two-day course. Results from a Trial of the Senolytic Fisetin in a Single Individual with Autoimmunity (Community discussion · Accessed 2026-09-30)
Mayo-style pulse (dominant template): ~20 mg/kg body weight oral per day for 2 consecutive days. [trial]
Daily and lower intermittent use are separate. The preserved daily band is 100–500 mg/day; one opened comment reports 100 mg three times daily. The older record also includes 100 mg twice daily for two days. Neither pattern is equivalent to a weight-based pulse. Results from a Trial of the Senolytic Fisetin in a Single Individual with Autoimmunity (Community discussion · Accessed 2026-09-30)
Extended and extreme experiments are outliers. Older logs include about 1 g/day for 10–15 days, multi-day 1.2 g/day and approximately 3 g single days. An opened Reddit experiment used 4 g nightly plus BioPerine 40 mg; its early “no negatives” update later changed. Mega dose fisetin experience (Personal report · Accessed 2026-09-30)
Source context — High dose Fisetin (1500MG) as senolytic: Unverified self-reports; mixed formulations and rapamycin co-use. Repeated couple comment is one account. No dose-response or tissue-repair measurement.
Source context — Fisetin protocol: One brief discussion, not population prevalence or comparative efficacy; the reply's assertion that low doses are useless is unsupported.
Source context — Results from a Trial of the Senolytic Fisetin in a Single Individual with Autoimmunity: Article is secondary advocacy; comments are unverified and disease-specific. Inflammation changes do not establish autoimmune response or senolysis. Cancer-elimination assertion is not accepted.
Source context — Mega dose fisetin experience: Deleted author identity; short evolving log with co-agent, no complete long-term follow-up. A planned four-night course is not verified completion.
Half-life, onset & duration
| Felt onset | Reports range from next-day motivation to subtle changes around days 3–7 or later. Fatigue within eight hours was an adverse account. |
|---|---|
| Felt duration | No dependable single-dose benefit window is established. Some sinus-comfort or joint changes reportedly faded over weeks; flu-like symptoms lasted 1–4 days in older reports. |
| Human half-life | A 15-person study estimated parent fisetin half-life at 1.14 hours unformulated and 1.51 hours with FF-20. These are formulation-specific blood measurements, not benefit durations. |
Notes
Next-day reports differ from changes noticed days later. A LongeCity log describes next-day motivation after nighttime use. The older record puts subtle joint, sinus or recovery changes around days 3–7 or later. Another user felt unchanged after two days at 1,500 mg. There is no shared onset for benefit. Fisetin: Senolytic! — page 28 (Personal report · Accessed 2026-09-30) · Mega dose fisetin experience (Personal report · Accessed 2026-09-30)
An unwanted effect can arrive first. One multi-ingredient pulse account describes fatigue within eight hours, while allowing possible illness. That is an adverse-symptom onset, not evidence that cell clearance started. Fatigue After Taking Senolytic? (Personal report · Accessed 2026-09-30)
No dependable benefit duration after one dose. Older logs describe some nasal or joint changes fading over weeks; others report improvement during repeated months of use. A monthly calendar does not mean each dose provides a month of benefit. High dose Fisetin (1500MG) as senolytic (Personal report · Accessed 2026-09-30)
Older post-pulse flu-like reports: 1–4 days. The preserved account describes feverishness, aches, fatigue or increased appetite after some high-amount pulses. Their proposed cell-debris explanation was not established.
Human oral half-life depends on the tested form. In a 15-volunteer study, parent fisetin half-life was 1.14 hours unformulated versus 1.51 hours with FF-20. Geraldol, a metabolite, was 1.18 versus 1.59 hours. These are study estimates, not community measurements or benefit durations. Krishnakumar et al. — human oral fisetin formulation pharmacokinetics (Official context · Accessed 2026-09-30)
Source context — Fisetin: Senolytic! — page 28: Self-assessed outcomes and causal guesses; escalation, food and baseline health confound interpretation. Page contains repeated quotations of the same reports.
Source context — Mega dose fisetin experience: Deleted author identity; short evolving log with co-agent, no complete long-term follow-up. A planned four-night course is not verified completion.
Source context — Fatigue After Taking Senolytic?: Multiple co-agents, possible virus and different users; no proof of senolysis. No amount specified for #11.
Source context — High dose Fisetin (1500MG) as senolytic: Unverified self-reports; mixed formulations and rapamycin co-use. Repeated couple comment is one account. No dose-response or tissue-repair measurement.
Source context — Krishnakumar et al. — human oral fisetin formulation pharmacokinetics: Small single-dose industry-funded study with developer/vendor affiliations; dose-normalized exposure values. Measures neither lifespan nor clinical senolysis; not all metabolites measured.
Cycles people discuss
| Pulse calendars | Two or three pulse days followed by monthly, quarterly or roughly six-month gaps appear in different accounts. No lifelong healthy-adult schedule is established. |
|---|---|
| Daily alternative | Continuous 100–500 mg/day is discussed as a polyphenol habit; the posts do not settle whether everyone needs breaks. |
Notes
Two or three pulse days, then widely different gaps. Opened accounts use monthly repeats or roughly six-month gaps. The older record also includes monthly courses for about three months, every 2–3 months, quarterly use and restarts after longer breaks. No lifelong healthy-adult schedule is established. High dose Fisetin (1500MG) as senolytic (Personal report · Accessed 2026-09-30)
Daily use follows a different rationale. Continuous 100–500 mg/day is discussed as a polyphenol habit rather than the hit-and-run pulse idea. Neither the claim that low amounts are useless nor the claim that everyone must cycle is settled by these posts. Fisetin protocol (Community discussion · Accessed 2026-09-30)
Source context — High dose Fisetin (1500MG) as senolytic: Unverified self-reports; mixed formulations and rapamycin co-use. Repeated couple comment is one account. No dose-response or tissue-repair measurement.
Source context — Fisetin protocol: One brief discussion, not population prevalence or comparative efficacy; the reply's assertion that low doses are useless is unsupported.
Stacks
| Polyphenol combinations | Quercetin, luteolin, resveratrol, piperlongumine and theaflavin blends appear. Quercetin amounts around 500–1,250 mg are reported without a validated ratio. |
|---|---|
| Absorption and longevity stacks | Meals/oils, piperine and enhanced products are used to chase absorption. Calendars also include NMN/NR, spermidine, metformin or rapamycin; combined benefit is unestablished. |
Notes
Blends obscure which ingredient did what. Earlier discussion pairs fisetin with quercetin, luteolin, resveratrol, piperlongumine or theaflavin blends, alongside rapamycin, NMN, NR, spermidine and metformin calendars, plus seasonal quercetin, zinc and vitamin C stacks. Quercetin co-amounts of roughly 500–1,250 mg appear, without a fixed validated ratio. Separate D+Q months and FOXO4-DRI comparisons are discussion, not interchangeable treatments.
Absorption claims fuel dose disagreements. People add meals, oils, piperine or enhanced products. One thread repeats an 18-fold vendor claim and converts it into a smaller liposomal amount, without verifying human equivalence. Taste, pill count, purity claims, fasting and concurrent training/sleep changes further complicate comparisons. The older storage note follows each product's label: cool, dry and protected from light. Mega dose fisetin experience (Personal report · Accessed 2026-09-30)
Longevity backbone adjacency: Stacked in calendars with NMN/NR, resveratrol, spermidine, metformin interest, or weekly rapamycin—different mechanisms; no standard multi-agent RCT for the full cocktail. [community]
Source context — Mega dose fisetin experience: Deleted author identity; short evolving log with co-agent, no complete long-term follow-up. A planned four-night course is not verified completion.
Watch for
| Reported downsides | Stomach upset, loose stools, headache, light-headedness, rash-like symptoms, sleep disruption, sweats, fatigue and lower mood appear in reports. |
|---|---|
| Medicines and special populations | A trial protocol excludes warfarin/related anticoagulants, substantial liver/kidney disease and pregnancy/nursing, and flags drug-metabolism concerns. These safeguards are not instructions to stop medicines. |
| No proof of die-off | Fatigue does not establish cell clearance. Product identity and years of repeated high-amount use remain uncertain. |
Notes
Stomach, sleep and mental effects appear in reports. The older account includes nausea, loose stools, headache, light-headedness, warmth/itch, rash-like symptoms and disrupted sleep. Fresh logs add intense dreams, sweats, fatigue and lower mood. Absence of an immediate reaction is not long-term safety evidence. Mega dose fisetin experience (Personal report · Accessed 2026-09-30) · massive, long-lasting brainfog after last Fisetin dose (Personal report · Accessed 2026-09-30)
Bleeding, medicines and special populations need separate consideration. A trial protocol excludes warfarin or related anticoagulants, substantial liver/renal disease and pregnancy/nursing; it flags drug-metabolism concerns. These are research safeguards, not a proven complete interaction list or instructions to hold a medicine. NCT04210986 — fisetin osteoarthritis trial protocol, version 007 (Official context · Accessed 2026-09-30)
“Die-off” does not explain a reaction. Forums speculate about clearing cell debris, slowed wound healing and effects on useful senescence. Old notes also raise laboratory topoisomerase concerns. These ideas do not diagnose fatigue, establish cancer risk or make escalating amounts safe. Mega dose fisetin experience (Personal report · Accessed 2026-09-30)
Product identity and long-term safety remain uncertain. The preserved discussion flags mislabeling, contaminants and extract variability, plus missing high-amount data in children or years of repeated pulses. “Natural,” a quiet first course and a seller's assay claim do not establish safety.
Source context — Mega dose fisetin experience: Deleted author identity; short evolving log with co-agent, no complete long-term follow-up. A planned four-night course is not verified completion.
Source context — massive, long-lasting brainfog after last Fisetin dose: Retrospective amounts uncertain; no independent diagnosis or product verification. Replies are distinct experiences, not confirmations of causation.
Source context — NCT04210986 — fisetin osteoarthritis trial protocol, version 007: Research exclusions indicate risk management, not quantified interaction incidence. This 2021 protocol describes two courses; 2025 results describe three. Medication holds are investigator-specific and not reader instructions.
Full notes
Fisetin is a plant flavonol sold as an oral supplement. Longevity communities discuss it for aging cells, joint comfort and mental sharpness, usually as an occasional high-amount pulse or a smaller daily habit. Reports include improvement, no noticeable change and unwanted effects; feeling different does not show that aging cells were removed.
Why fisetin attracts longevity interest
- A plant compound with two different use stories. Flavonol means a type of plant polyphenol. Senescent cells have stopped dividing and can release inflammatory signals; “senolytic” means an agent intended to remove them. Pulse users pursue that idea, while daily users often seek ordinary symptom comfort. These goals are different. Animal context Community Reddit r/blueprint_
- Oral forms matter. Capsules, powder, Novusetin extracts, liposomal liquids and hydrogel complexes appear in discussions. People argue about meals, oils, fasting and split versus single daily amounts. Equal milligrams on two labels do not establish equal absorption. Community Personal report Community
Benefits people hope for or report
- Less stiffness, easier movement and better well-being. One monthly-pulse reply described better joints after typing, better-looking skin and less-grey hair. Another poster's old back injury flared instead. These observations do not establish cartilage repair or reversal of aging. Personal report
- Easier word-finding, nasal comfort and other reported changes. Older accounts mention word-finding, training drive, nasal comfort and reduced nighttime urinary urgency. They also include people noticing nothing for weeks. These remain separate reported experiences, rather than a single expected benefit. Community
- Human joint results temper the testimonials. A 2025 primary conference abstract reported no significant pain, function or cartilage benefit versus placebo in a 74-person knee-osteoarthritis trial. That result applies to its formulation and three-course schedule, not every community experiment. Official context
Doses people discuss
Reported amounts retain their own route, form and calendar. They are not instructions.
- Oral pulses: 1,000–1,800 mg total per day in the older record. Opened examples differ: 1,500 mg on each of 2–3 days, approximately 1,700 mg on each monthly pulse day, or 1,000 mg/day for three days with quercetin 1,200 mg/day. These are reports, not a recommended range. Community Personal report Reddit r/blueprint_
- 20 mg/kg/day is copied from trial language. The community's 1,400 mg/day example for 70 kg, or 1,200–1,600 mg/day for 60–80 kg, is arithmetic from that study template. It is a daily total on each pulse day, not the total for a two-day course. Fight Aging! Community
- Daily and lower intermittent use are separate. The preserved daily band is 100–500 mg/day; one opened comment reports 100 mg three times daily. The older record also includes 100 mg twice daily for two days. Neither pattern is equivalent to a weight-based pulse. Community Fight Aging!
- Extended and extreme experiments are outliers. Older logs include about 1 g/day for 10–15 days, multi-day 1.2 g/day and approximately 3 g single days. An opened Reddit experiment used 4 g nightly plus BioPerine 40 mg; its early “no negatives” update later changed. Community Personal report
Half-life: what the community can establish
- No independently measured community half-life in these accounts. People discuss short circulation time and absorption aids, but their logs do not measure clearance. Half-life is the time a measured amount takes to halve; lingering symptoms or weeks between pulses cannot determine it. Human-study and mouse figures are separately labeled below. Community Personal report
Onset: when people notice something
- Next-day reports differ from changes noticed days later. A LongeCity log describes next-day motivation after nighttime use. The older record puts subtle joint, sinus or recovery changes around days 3–7 or later. Another user felt unchanged after two days at 1,500 mg. There is no shared onset for benefit. Personal report Community Personal report
- An unwanted effect can arrive first. One multi-ingredient pulse account describes fatigue within eight hours, while allowing possible illness. That is an adverse-symptom onset, not evidence that cell clearance started. Personal report
Duration: how long reported changes last
- No dependable benefit duration after one dose. Older logs describe some nasal or joint changes fading over weeks; others report improvement during repeated months of use. A monthly calendar does not mean each dose provides a month of benefit. Community Personal report
- Unwanted effects can outlast dosing. A LongeCity author recalls 400 mg one day and 500 mg the next, followed by brain fog for weeks. Product identity and causation were not independently checked. Personal report
- Older post-pulse flu-like reports: 1–4 days. The preserved account describes feverishness, aches, fatigue or increased appetite after some high-amount pulses. Their proposed cell-debris explanation was not established. Community
Cycles and time off
- Two or three pulse days, then widely different gaps. Opened accounts use monthly repeats or roughly six-month gaps. The older record also includes monthly courses for about three months, every 2–3 months, quarterly use and restarts after longer breaks. No lifelong healthy-adult schedule is established. Personal report Community
- Daily use follows a different rationale. Continuous 100–500 mg/day is discussed as a polyphenol habit rather than the hit-and-run pulse idea. Neither the claim that low amounts are useless nor the claim that everyone must cycle is settled by these posts. Community Reddit r/blueprint_
Cautions that matter
- Stomach, sleep and mental effects appear in reports. The older account includes nausea, loose stools, headache, light-headedness, warmth/itch, rash-like symptoms and disrupted sleep. Fresh logs add intense dreams, sweats, fatigue and lower mood. Absence of an immediate reaction is not long-term safety evidence. Community Personal report Personal report
- Bleeding, medicines and special populations need separate consideration. A trial protocol excludes warfarin or related anticoagulants, substantial liver/renal disease and pregnancy/nursing; it flags drug-metabolism concerns. These are research safeguards, not a proven complete interaction list or instructions to hold a medicine. Official context
- “Die-off” does not explain a reaction. Forums speculate about clearing cell debris, slowed wound healing and effects on useful senescence. Old notes also raise laboratory topoisomerase concerns. These ideas do not diagnose fatigue, establish cancer risk or make escalating amounts safe. Community Personal report
- Product identity and long-term safety remain uncertain. The preserved discussion flags mislabeling, contaminants and extract variability, plus missing high-amount data in children or years of repeated pulses. “Natural,” a quiet first course and a seller's assay claim do not establish safety. Community
What people experience and argue about
- No change remains a real outcome. The older record includes little acute buzz or no change for weeks. A Fight Aging commenter reported unchanged psoriasis/arthritis with daily 100–500 mg or intermittent 3–5 g; another described phlegm relief with daily use and changing meal timing. Neither verifies disease treatment. Fight Aging!
- Feeling better can coexist with feeling worse. One escalating LongeCity log described more motivation, then diarrhea/exhaustion after its final 2.5 g day, followed by lighter movement on days 2–4. Another Reddit author linked recurrent back pain to fisetin, including a later 200 mg trial; the scar-tissue explanation was their guess. Personal report Personal report
- Fatigue and altered perception are reasons people reconsider. A Rapamycin.news poster stopped prolonged daily use after vivid dreams and feeling detached at work. That is one account with no stated amount. Other users in the thread describe little fatigue, so it is not a universal reaction. Personal report
- Blends obscure which ingredient did what. Earlier discussion pairs fisetin with quercetin, luteolin, resveratrol, piperlongumine or theaflavin blends, alongside rapamycin, NMN, NR, spermidine and metformin calendars, plus seasonal quercetin, zinc and vitamin C stacks. Quercetin co-amounts of roughly 500–1,250 mg appear, without a fixed validated ratio. Separate D+Q months and FOXO4-DRI comparisons are discussion, not interchangeable treatments. Community
- Absorption claims fuel dose disagreements. People add meals, oils, piperine or enhanced products. One thread repeats an 18-fold vendor claim and converts it into a smaller liposomal amount, without verifying human equivalence. Taste, pill count, purity claims, fasting and concurrent training/sleep changes further complicate comparisons. The older storage note follows each product's label: cool, dry and protected from light. Personal report Community
Research context behind the numbers
- Human oral half-life depends on the tested form. In a 15-volunteer study, parent fisetin half-life was 1.14 hours unformulated versus 1.51 hours with FF-20. Geraldol, a metabolite, was 1.18 versus 1.59 hours. These are study estimates, not community measurements or benefit durations. Official context
- Formulation milligrams are not all fisetin. That study compared 1,000 mg unformulated material with 1,000 mg FF-20 containing 192 mg fisetin. Its reported 26.9-fold exposure difference was dose-normalized and industry-funded; it is not a conversion rule for other brands. Official context
- The older mouse half-lives are a different experiment. A primary abstract reports 0.09-hour rapid and 3.1-hour terminal decline after 223 mg/kg intraperitoneally in mice. Neither supplies human oral timing. Animal context
- Mouse pulse and lifespan experiments differ. The 2018 work includes 100 mg/kg/day by oral gavage for five days in aged mice; its lifespan experiment used chronic dietary fisetin. Human tissue explants are not people taking supplements. These findings explain the interest without proving human lifespan extension. Animal context
- Mouse-to-human arithmetic is another circulated estimate. Older forums scale a mouse regimen to about 500 mg/day for five days in a 60 kg adult. That calculation differs from the trial-origin 20 mg/kg pulse; neither calculation demonstrates an effective self-treatment amount. Community
